Cargando…

Peri-implantitis and Severity Level

Objectives  Different diagnostic criteria were used for diagnosis of peri-implant diseases. The aim of this cross-sectional study was to explore prevalence of peri-implant diseases and subclassify peri-implantitis based on different levels of radiographic and clinical findings. Materials and Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Elemek, Eser, Agrali, Omer Birkan, Kuru, Bahar, Kuru, Leyla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical and Scientific Publishers Private Ltd. 2020
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069736/
https://www.ncbi.nlm.nih.gov/pubmed/32168529
http://dx.doi.org/10.1055/s-0040-1701162
_version_ 1783505835659362304
author Elemek, Eser
Agrali, Omer Birkan
Kuru, Bahar
Kuru, Leyla
author_facet Elemek, Eser
Agrali, Omer Birkan
Kuru, Bahar
Kuru, Leyla
author_sort Elemek, Eser
collection PubMed
description Objectives  Different diagnostic criteria were used for diagnosis of peri-implant diseases. The aim of this cross-sectional study was to explore prevalence of peri-implant diseases and subclassify peri-implantitis based on different levels of radiographic and clinical findings. Materials and Methods  Two hundred patients having 655 dental implants were included in this study. In addition to clinical measurements, standard long-cone parallel technique was used to evaluate marginal bone level around implants. Following diagnosis of peri-implant diseases, peri-implantitis was further subclassified using a severity leveling in terms of marginal bone level and probing depth. Results  Mean age of 200 subjects was 52.8 ± 12.2 years and 63% were females. In total, bleeding on probing was present in 93% and suppuration in 27% of implants. On subject basis, 2.5% were diagnosed as healthy, 28% with peri-implant mucositis (PM), and 69.5% with peri-implantitis, whereas on implant basis, 3.6% were healthy, 36% presented PM, and 60.4% peri-implantitis. Furthermore, when severity leveling was applied, peri-implantitis prevalence changed markedly and ranged from 14.5 to 31.0% at the subject level and from 10.0 to 22.0% at the implant level. Subgingival restoration margins were observed in 70.6% of patients for implants with PM and in 44% patients for implants with peri-implantitis. Most of the implants with peri-implantitis were with platform match (71.5%). Conclusions  Applying different thresholds to the peri-implantitis definition yielded different prevalence rates ranging from 10 to 31%. As no established diagnostic criteria are being used today, results from clinical studies may not reflect the true disease prevalence.
format Online
Article
Text
id pubmed-7069736
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Thieme Medical and Scientific Publishers Private Ltd.
record_format MEDLINE/PubMed
spelling pubmed-70697362020-03-18 Peri-implantitis and Severity Level Elemek, Eser Agrali, Omer Birkan Kuru, Bahar Kuru, Leyla Eur J Dent Objectives  Different diagnostic criteria were used for diagnosis of peri-implant diseases. The aim of this cross-sectional study was to explore prevalence of peri-implant diseases and subclassify peri-implantitis based on different levels of radiographic and clinical findings. Materials and Methods  Two hundred patients having 655 dental implants were included in this study. In addition to clinical measurements, standard long-cone parallel technique was used to evaluate marginal bone level around implants. Following diagnosis of peri-implant diseases, peri-implantitis was further subclassified using a severity leveling in terms of marginal bone level and probing depth. Results  Mean age of 200 subjects was 52.8 ± 12.2 years and 63% were females. In total, bleeding on probing was present in 93% and suppuration in 27% of implants. On subject basis, 2.5% were diagnosed as healthy, 28% with peri-implant mucositis (PM), and 69.5% with peri-implantitis, whereas on implant basis, 3.6% were healthy, 36% presented PM, and 60.4% peri-implantitis. Furthermore, when severity leveling was applied, peri-implantitis prevalence changed markedly and ranged from 14.5 to 31.0% at the subject level and from 10.0 to 22.0% at the implant level. Subgingival restoration margins were observed in 70.6% of patients for implants with PM and in 44% patients for implants with peri-implantitis. Most of the implants with peri-implantitis were with platform match (71.5%). Conclusions  Applying different thresholds to the peri-implantitis definition yielded different prevalence rates ranging from 10 to 31%. As no established diagnostic criteria are being used today, results from clinical studies may not reflect the true disease prevalence. Thieme Medical and Scientific Publishers Private Ltd. 2020-02 2020-03-13 /pmc/articles/PMC7069736/ /pubmed/32168529 http://dx.doi.org/10.1055/s-0040-1701162 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Elemek, Eser
Agrali, Omer Birkan
Kuru, Bahar
Kuru, Leyla
Peri-implantitis and Severity Level
title Peri-implantitis and Severity Level
title_full Peri-implantitis and Severity Level
title_fullStr Peri-implantitis and Severity Level
title_full_unstemmed Peri-implantitis and Severity Level
title_short Peri-implantitis and Severity Level
title_sort peri-implantitis and severity level
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7069736/
https://www.ncbi.nlm.nih.gov/pubmed/32168529
http://dx.doi.org/10.1055/s-0040-1701162
work_keys_str_mv AT elemekeser periimplantitisandseveritylevel
AT agraliomerbirkan periimplantitisandseveritylevel
AT kurubahar periimplantitisandseveritylevel
AT kuruleyla periimplantitisandseveritylevel